OR7E19P: A Potential Drug Target Or Biomarker (G26651)
OR7E19P: A Potential Drug Target Or Biomarker
OR7E19P (OR19-7) is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the OR7 family of transmembrane proteins, which are involved in various cellular processes , including signaling and signaling transduction. OR7E19P is unique due to its potential as a drug target or biomarker, as it has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The OR7 family of proteins was identified through a combination of genetic and biochemical studies. OR7E19P is a member of the OR7 family, which includes OR7A, OR7B, OR7C, and OR7D. These proteins are characterized by the presence of a unique C-terminus domain , which is composed of a series of amino acids that are involved in the formation of a transmembrane complex. The C-terminus domain is responsible for the protein's ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs).
OR7E19P is a 19-kDa protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is characterized by the presence of a unique C-terminus domain that is composed of a series of amino acids that are involved in the formation of a transmembrane complex. The C-terminus domain is responsible for the protein's ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs).
OR7E19P has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of OR7E19P are associated with poor prognosis in patients with pancreatic cancer, a leading cause of cancer- related deaths. Additionally, OR7E19P has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
In addition to its potential as a drug target or biomarker, OR7E19P is also of interest due to its unique structure and its ability to interact with various signaling molecules. The C-terminus domain of OR7E19P is known to be involved in the formation of a transmembrane complex, which suggests that it may be involved in the regulation of various cellular processes that occur at the membrane. This domain is also known to be involved in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane.
OR7E19P has also been shown to be involved in the regulation of cellular signaling pathways that are important for various cellular processes, including cell growth, differentiation, and survival. For example, studies have shown that OR7E19P is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular signaling pathways that are important for cell growth, differentiation, and survival.
In conclusion, OR7E19P is a protein that is of interest due to its unique structure and its ability to interact with various signaling molecules. The C-terminus domain of OR7E19P is known to be involved in the formation of a transmembrane complex, which suggests that it may be involved in the regulation of various cellular processes that occur at the membrane. Additionally, OR7E19P has been shown to be involved in the regulation of cellular signaling pathways that are important for various cellular processes, including cell growth, differentiation, and survival. As a result, OR7E19P is a potential drug target or biomarker that may be useful in the development of new treatments for a variety of diseases.
Protein Name: Olfactory Receptor Family 7 Subfamily E Member 19 Pseudogene
The "OR7E19P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR7E19P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex | ORM1 | ORM2 | ORMDL1 | ORMDL2 | ORMDL3 | OS9 | OSBP | OSBP2 | OSBPL10 | OSBPL11 | OSBPL1A | OSBPL2 | OSBPL3 | OSBPL5 | OSBPL6 | OSBPL7 | OSBPL8 | OSBPL9 | OSCAR | OSCP1 | OSER1 | OSER1-DT | OSGEP | OSGEPL1 | OSGEPL1-AS1 | OSGIN1 | OSGIN2 | OSM
